| Date Filed | Type | Description |
| 03/15/2023 |
4
| Throdahl Mark C (Director) has filed a Form 4 on ORTHOPEDIATRICS CORP|
Txns:
| Granted 12,266 shares
@ $0 |
|
| 03/07/2023 |
4
| Throdahl Mark C (Director) has filed a Form 4 on ORTHOPEDIATRICS CORP|
Txns:
| Sold 4,515 shares
@ $43.8254, valued at
$197.9k
|
|
| 01/10/2023 |
5
| Throdahl Mark C (Director) has filed a Form 5 on ORTHOPEDIATRICS CORP |
| 03/16/2022 |
4
| Throdahl Mark C (Director) has filed a Form 4 on ORTHOPEDIATRICS CORP|
Txns:
| Granted 10,363 shares
@ $0 |
|
| 03/03/2022 |
4
| Throdahl Mark C (Director) has filed a Form 4 on ORTHOPEDIATRICS CORP|
Txns:
| Sold 5,961 shares
@ $58.6, valued at
$349.3k
|
|
| 12/21/2021 |
4
| Throdahl Mark C (Director) has filed a Form 4 on ORTHOPEDIATRICS CORP|
Txns:
| Gifted 3,000 shares
@ $0 |
|
| 08/04/2021 |
4
| Throdahl Mark C (Director) has filed a Form 4 on ORTHOPEDIATRICS CORP|
Txns:
| Sold 4,774 shares
@ $65.4, valued at
$312.2k
|
|
| 08/03/2021 |
4
| Throdahl Mark C (Director) has filed a Form 4 on ORTHOPEDIATRICS CORP|
Txns:
| Sold 15,226 shares
@ $65.88, valued at
$1M
|
|
| 03/03/2021 |
4
| Throdahl Mark C (CEO) has filed a Form 4 on ORTHOPEDIATRICS CORP|
Txns:
| Sold 5,097 shares
@ $55.88, valued at
$284.8k
Granted 5,277 shares
@ $0 |
|
| 02/12/2021 |
5
| Throdahl Mark C (CEO) has filed a Form 5 on ORTHOPEDIATRICS CORP |
| 02/09/2021 |
4
| Throdahl Mark C (President and CEO) has filed a Form 4 on ORTHOPEDIATRICS CORP|
Txns:
| Sold 12,651 shares
@ $50.34, valued at
$636.9k
|
|
| 02/05/2021 |
4
| Throdahl Mark C (President and CEO) has filed a Form 4 on ORTHOPEDIATRICS CORP|
Txns:
| Sold 7,349 shares
@ $50.18, valued at
$368.8k
|
|
| 06/29/2020 |
4
| Throdahl Mark C (President and CEO) has filed a Form 4 on ORTHOPEDIATRICS CORP|
Txns:
| Granted 30,000 shares
@ $44.08, valued at
$1.3M
Sold 13,389 shares
@ $42.88, valued at
$574.1k
|
|
| 05/21/2020 |
4
| Throdahl Mark C (President and CEO) has filed a Form 4 on ORTHOPEDIATRICS CORP|
Txns:
| Sold 670 shares
@ $46.56, valued at
$31.2k
Sold 402 shares
@ $46.56, valued at
$18.7k
Sold 402 shares
@ $46.57, valued at
$18.7k
Exercised 670 options to buy
@ $30.97, valued at
$20.7k
Exercised 402 options to buy
@ $30.97, valued at
$12.4k
|
|
| 03/04/2020 |
4
| Throdahl Mark C (President and CEO) has filed a Form 4 on ORTHOPEDIATRICS CORP|
Txns:
| Granted 10,049 shares
@ $0 |
|
| 12/13/2019 |
4
| Throdahl Mark C (President and CEO) has filed a Form 4 on ORTHOPEDIATRICS CORP|
Txns:
| Sold 10,000 shares
@ $34.31, valued at
$343.1k
|
|
| 06/17/2019 |
4
| Throdahl Mark C (President and CEO) has filed a Form 4 on ORTHOPEDIATRICS CORP|
Txns:
| Gifted 1,000 shares
@ $0 |
|
| 03/01/2019 |
4
| Throdahl Mark C (President and CEO) has filed a Form 4 on ORTHOPEDIATRICS CORP|
Txns:
| Granted 14,246 shares
@ $0 |
|
| 04/16/2018 |
4
| Throdahl Mark C (President and CEO) has filed a Form 4 on ORTHOPEDIATRICS CORP|
Txns:
| Sold 27,549 shares
@ $17.92, valued at
$493.7k
|
|
| 03/01/2018 |
4
| Throdahl Mark C (President and CEO) has filed a Form 4 on ORTHOPEDIATRICS CORP|
Txns:
| Granted 12,000 shares
@ $0 |
|
| 03/01/2018 |
3/A
| Throdahl Mark C (President and CEO) has filed a Form 3/A on ORTHOPEDIATRICS CORP |
| 10/16/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/11/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/15/2009 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |